This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (23) Citing Articles via Google Scholar Google Scholar Articles by Paller, A. S. Articles by Jackson, A. Search for Related Content PubMed PubMed Citation Articles by Paller, A. S. Articles by Jackson, A. Social Bookmarking                   What's this?

Perceptions of Physicians and Pediatric Patients About Atopic Dermatitis, Its Impact, and Its Treatment

Northwestern University Medical School and Children's Memorial Hospital, Chicago, Illinois

Robert O. Mcalister, PhD

National Eczema Association for Science and Education, Portland, Oregon

Joseph J. Doyle, RPh, MBA

Aventis Pharmaceuticals, Bridgewater, NJ

Archi Jackson, PharmD

Prescription Solutions, Costa Mesa, Calif

The National Eczema Association for Science and Education surveyed 429 patients with atopic dermatitis or their parents and 303 physicians about atopic dermatitis, its effect on quality of life (QOL), and the adequacy of available treatments. The physician survey focused on disease severity and management; the patient survey, on disease severity, impact on QOL, and treatment preferences. Physician and patient/parent respondents generally agreed about their assessments of disease severity, poor effectiveness of over-the-counter products, and the need for more patient support groups and toll-free phone information. Atopic dermatitis significantly impacts QOL in children, particularly in those with moderate-to-severe disease. New treatments should offer enhanced efficacy, less frequent application, and fewer adverse effects.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. C. Krakowski, L. F. Eichenfield, and M. A. Dohil Management of Atopic Dermatitis in the Pediatric Population Pediatrics, October 1, 2008; 122(4): 812 - 824. [Abstract] [Full Text] [PDF]

				A. B. Fleischer Jr Diagnosis and Management of Common Dermatoses in Children: Atopic, Seborrheic, and Contact Dermatitis Clinical Pediatrics, May 1, 2008; 47(4): 332 - 346. [Abstract] [PDF]

				K. A. Horii, S. D. Simon, D. Y. Liu, and V. Sharma Atopic Dermatitis in Children in the United States, 1997 2004: Visit Trends, Patient and Provider Characteristics, and Prescribing Patterns Pediatrics, September 1, 2007; 120(3): e527 - e534. [Abstract] [Full Text] [PDF]

				J. S. LeBovidge, S. D. Kelley, A. Lauretti, E. P. Bailey, K. G. Timmons, A. K. Timmons, M. Van Horn, L. R. Blakely, and L. C. Schneider Integrating Medical and Psychological Health Care for Children with Atopic Dermatitis J. Pediatr. Psychol., June 1, 2007; 32(5): 617 - 625. [Abstract] [Full Text] [PDF]

				L. A. Schachner, C. Lamerson, M. P. Sheehan, M. Boguniewicz, J. Mosser, S. Raimer, T. Shull, E. Jaracz, and for the US Tacrolimus Ointment Study Group Tacrolimus Ointment 0.03% Is Safe and Effective for the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Patients: Results From a Randomized, Double-Blind, Vehicle-Controlled Study Pediatrics, September 1, 2005; 116(3): e334 - e342. [Abstract] [Full Text] [PDF]